EphB4 and its sole ligand EphrinB2 are overexpressed in all primary and metastatic tumors, with EphB4 overexpression correlating with advanced stage disease and lymph node metastasis. Here, EPHB4 is linked to metastatic malignant neoplasm in the lymph nodes.